Distortion-product otoacoustic emission: Early detection in deferoxamine induced ototoxicity
Authors:
- Emilio DelehayeEDEmilio Delehaye
- Saverio CapobiancoSCSaverio Capobianco
- Ivano Bruno BertettoIBIvano Bruno Bertetto
- Francesco MeloniFMFrancesco Meloni
- 1 June 2008
- journal article
- research article
- Published by Elsevier in Auris Nasus Larynx
- Vol. 35 (2) , 198-202
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Auditory and Visual Toxicity During Deferoxamine Therapy in Transfusion-Dependent PatientsJournal of Pediatric Hematology/Oncology, 2005
- Evaluation of the Incidence of Sensorineural Hearing Loss in Beta-Thalassemia major Patients under Regular Chelation Therapy with DesferrioxamineActa Haematologica, 2002
- Evoked otoacoustic emissions — an approach for monitoring cisplatin induced ototoxicity in childrenInternational Journal of Pediatric Otorhinolaryngology, 2001
- Audiological evaluation in adult beta-thalassemia major patients under regular chelation treatmentPharmacological Research, 2000
- High-Frequency Hearing Influences Lower-Frequency Distortion-Product Otoacoustic EmissionsJAMA Otolaryngology–Head & Neck Surgery, 1999
- Otoacoustic emissions: An approach for monitoring aminoglycoside‐induced ototoxicityThe Laryngoscope, 1994
- Test/Retest Reliability of Distortion-ProductEar & Hearing, 1992
- A review of otoacoustic emissionsThe Journal of the Acoustical Society of America, 1991
- Outer Hair Cell Electromotility and Otoacoustic EmissionsEar & Hearing, 1990
- Effect of cisplatin on hair cell morphology and lateral wall Na, K-ATPase activityHearing Research, 1987